Use of complementary medications among older adults with cancer.

Cancer
Ronald J MaggioreCancer and Aging Research Group

Abstract

Little is known about complementary medication use among older adults with cancer, particularly those who are receiving chemotherapy. The objective of this study was to evaluate the prevalence of complementary medication use and to identify the factors associated with its use among older adults with cancer. The prevalence of complementary medication use (defined as herbal agents, minerals, or other dietary supplements, excluding vitamins) was evaluated in a cohort of adults aged ≥65 years who were about to start chemotherapy for their cancer. The associations between complementary medication use and patient characteristics (sociodemographics; comorbidities; and functional, nutritional, psychological, and cognitive status), medication use (number of medications and concurrent vitamin use), and cancer characteristics (type and stage) were analyzed. The cohort included 545 patients (mean age, 73 years; range, 65-91 years; 52% women) with cancer (61% stage IV). Seventeen percent of these patients (N = 93) reported using ≥1 complementary medication; the mean number of complementary medications among users was 2 (range, 1-10 medications). Complementary medication use was associated with 1) earlier cancer stage (29% had stage I-II dis...Continue Reading

References

Jun 1, 1983·The American Journal of Psychiatry·R KatzmanH Schimmel
Jun 1, 1983·Acta Psychiatrica Scandinavica·A S Zigmond, R P Snaith
Oct 1, 1995·Journal of Geriatric Psychiatry and Neurology·C KawasR Brookmeyer
Jun 3, 1999·Cancer Practice·G K WyattK C Beckrow
Jun 3, 1999·The New England Journal of Medicine·H J BursteinJ C Weeks
Jan 6, 2000·Journal of the National Cancer Institute·M M LeeD Eisenberg
Jul 13, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M A RichardsonS E Singletary
Sep 17, 2002·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Ruth E PattersonLynn M Marshall
Oct 3, 2002·American Journal of Public Health·Marion M LeeMargaret R Wrensch
Dec 10, 2002·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Dianne M ShumayHisako Kakai
Mar 3, 2004·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Jeannine S McCuneGeorgiana K Ellis
Jun 16, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alex SparreboomWilliam D Figg
Dec 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Grace K DyAlex A Adjei
Feb 16, 2005·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Jennifer S YatesLauren K Colman
Mar 3, 2005·The Annals of Pharmacotherapy·Jeffrey J Bruno, Jeffrey J Ellis
Apr 28, 2005·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Digant GuptaJames F Grutsch
Oct 6, 2005·Cancer·Arti HurriaAlice B Kornblith
Jul 4, 2006·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Joseph G GrzywaczThomas A Arcury
Oct 7, 2006·Journal of the Society for Integrative Oncology·John A AstinUNKNOWN Susan G. Komen Breast Cancer Foundation
Nov 8, 2006·Journal of the American Geriatrics Society·Richard L NahinUNKNOWN GEM Study Investigators
Jan 6, 2007·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Catalina LawsinLina Jandorf
Jul 3, 2007·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Alicia K MatthewsGini Fleming
Jul 20, 2007·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Kristine E EnsrudUNKNOWN Study of Osteoporotic Fractures Research Group
Aug 19, 2007·Journal of the American Geriatrics Society·Arti HurriaEva Kelly
Dec 1, 2007·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Corjena K CheungLinda L Halcon
Feb 27, 2008·Archives of Internal Medicine·Kristine E EnsrudSteven R Cummings
Dec 26, 2008·JAMA : the Journal of the American Medical Association·Dima M QatoStacy Tessler Lindau
Jan 29, 2009·Integrative Cancer Therapies·Silje EngdalOdd Georg Nilsen
Feb 28, 2009·Journal of the American Geriatrics Society·Kristine E EnsrudUNKNOWN Osteoporotic Fractures in Men Research Group
Aug 4, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Arti HurriaWilliam P Tew

❮ Previous
Next ❯

Citations

Apr 10, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Joshua BaumlJun J Mao
May 6, 2015·Expert Opinion on Drug Metabolism & Toxicology·Jasmeet C Singh, Stuart M Lichtman
May 10, 2016·Complementary Therapies in Clinical Practice·Fatma Pinar TurkmenogluTerken Baydar
Dec 20, 2019·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Danielle S ChunJennifer L Lund

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.